Total Payments
$256,614
2024 Payments
$8,706
Companies
30
Transactions
298
Medicare Patients
13,999
Medicare Billing
$1.6M
Payment Breakdown by Category
Research$164,793 (64.2%)
Consulting$83,235 (32.4%)
Food & Beverage$5,371 (2.1%)
Other$2,000 (0.8%)
Travel$1,206 (0.5%)
Education$8.45 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $164,793 | 19 | 64.2% |
| Consulting Fee | $83,235 | 31 | 32.4% |
| Food and Beverage | $5,371 | 242 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 0.8% |
| Travel and Lodging | $1,206 | 4 | 0.5% |
| Education | $8.45 | 1 | 0.0% |
Payments by Type
Research
$164,793
19 transactions
General
$91,821
279 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $191,649 | 66 | $0 (2022) |
| Bausch Health US, LLC | $27,070 | 7 | $0 (2021) |
| Galderma Laboratories, L.P. | $20,766 | 80 | $0 (2024) |
| ABBVIE INC. | $8,517 | 34 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $2,937 | 3 | $0 (2017) |
| Merz North America, Inc. | $2,853 | 23 | $0 (2023) |
| LEO Pharma AS | $1,174 | 3 | $0 (2017) |
| LEO Pharma Inc. | $369.65 | 25 | $0 (2023) |
| Incyte Corporation | $191.17 | 9 | $0 (2024) |
| GENZYME CORPORATION | $176.88 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,706 | 48 | ABBVIE INC. ($8,094) |
| 2023 | $627.50 | 32 | AbbVie Inc. ($265.01) |
| 2022 | $644.58 | 24 | ABBVIE INC. ($157.86) |
| 2021 | $14,700 | 40 | Allergan, Inc. ($12,141) |
| 2020 | $20,991 | 22 | Galderma Laboratories, L.P. ($16,473) |
| 2019 | $18,051 | 28 | Allergan Inc. ($16,344) |
| 2018 | $45,659 | 49 | Bausch Health US, LLC ($25,525) |
| 2017 | $147,235 | 55 | Allergan Inc. ($141,428) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $20.74 | General |
| 11/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.51 | General |
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $22.37 | General |
| 10/30/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $3.25 | General |
| 10/29/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $4.46 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $6.80 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/09/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $19.91 | General |
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $5.09 | General |
| 07/31/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| 07/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $7.44 | General |
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $5.64 | General |
| 07/01/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| 06/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.84 | General |
| 06/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $210.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| VOLUMA FOR THE TREATMENT OF HYPOPLASTIC CHIN | Allergan Inc. | $132,625 | 1 |
| A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS | Bausch Health US, LLC | $27,025 | 6 |
| EVALUATION OF EFFECTIVENESS AND SAFETY OF RADIESSE (+) FOR THE IMPROVEMENT OF JAWLINE VOLUME AND CONTOUR | MERZ NORTH AMERICA, INC. | $2,225 | 10 |
| A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris | Valeant Pharmaceuticals North America LLC | $1,550 | 1 |
| A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLECONTROLLED, PARALLEL-GROUP, CLINICAL STUDY COMPARING THE EFFICACY AND SAFETY OF IDP-126 GEL IN THE TREATMENT OF ACNE VULGARIS | Valeant Pharmaceuticals North America LLC | $1,368 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,875 | 5,743 | $465,770 | $326,116 |
| 2022 | 25 | 3,583 | 7,079 | $592,496 | $417,069 |
| 2021 | 25 | 3,812 | 6,997 | $625,106 | $447,765 |
| 2020 | 22 | 3,729 | 7,058 | $592,420 | $420,720 |
Total Patients
13,999
Total Services
26,877
Medicare Billing
$1.6M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 766 | 2,277 | $153,827 | $113,601 | 73.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 446 | 639 | $67,293 | $47,330 | 70.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 324 | 458 | $42,852 | $29,833 | 69.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 286 | 668 | $34,884 | $26,904 | 77.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 63 | 77 | $24,424 | $18,013 | 73.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 169 | $22,342 | $15,607 | 69.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 193 | 268 | $18,757 | $10,870 | 58.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 171 | 236 | $13,834 | $10,106 | 73.1% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 15 | 16 | $12,798 | $9,825 | 76.8% |
| 14020 | Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less | Office | 2023 | 13 | 15 | $11,116 | $8,559 | 77.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 56 | 69 | $20,226 | $7,949 | 39.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 48 | 58 | $6,803 | $4,328 | 63.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $7,161 | $4,283 | 59.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 24 | $4,229 | $3,208 | 75.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 31 | $4,141 | $2,975 | 71.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 109 | 511 | $3,459 | $2,639 | 76.3% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $3,650 | $2,608 | 71.5% |
| 69100 | Biopsy of ear | Office | 2023 | 34 | 42 | $4,236 | $2,022 | 47.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 40 | 40 | $3,001 | $1,881 | 62.7% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $3,430 | $1,348 | 39.3% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 24 | 26 | $1,132 | $821.51 | 72.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 22 | $1,311 | $725.71 | 55.4% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 12 | 14 | $864.00 | $679.04 | 78.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 826 | 2,638 | $181,624 | $137,727 | 75.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 600 | 865 | $93,169 | $64,710 | 69.5% |
About Dr. Kenneth Beer, MD
Dr. Kenneth Beer, MD is a MOHS-Micrographic Surgery healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699764993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Beer, MD has received a total of $256,614 in payments from pharmaceutical and medical device companies, with $8,706 received in 2024. These payments were reported across 298 transactions from 30 companies. The most common payment nature is "" ($164,793).
As a Medicare-enrolled provider, Beer has provided services to 13,999 Medicare beneficiaries, totaling 26,877 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatopathology, Procedural Dermatology
- Location West Palm Beach, FL
- Active Since 10/19/2005
- Last Updated 04/29/2024
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1699764993
Products in Payments
- BOTOX (Biological) $12,079
- ENSTILAR (Drug) $253.93
- KYBELLA (Biological) $253.91
- DUPIXENT (Biological) $177.75
- OPZELURA (Drug) $174.14
- Xeomin (Biological) $141.70
- BOTOX COSMETIC (Biological) $122.56
- SKYRIZI (Biological) $94.99
- Puraply (Medical Supply) $93.02
- DYSPORT (Biological) $79.80
- LIBTAYO (Biological) $77.64
- XEOMIN (Biological) $74.45
- SPEVIGO (Drug) $69.81
- COSENTYX (Biological) $68.10
- ADBRY (Biological) $61.13
- Otezla (Drug) $45.25
- AMELUZ (Drug) $41.57
- PICATO (Drug) $37.70
- COSENTYX (Drug) $27.42
- TALTZ (Drug) $25.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in West Palm Beach
Andrew Dorizas, M.d, M.D
MOHS-Micrographic Surgery — Payments: $295,433
MOHS-Micrographic Surgery $295,433
Larisa Kelley, M.d, M.D
MOHS-Micrographic Surgery — Payments: $226.25
MOHS-Micrographic Surgery $226.25
Laura Taylor, M.d, M.D
MOHS-Micrographic Surgery — Payments: $72.18
MOHS-Micrographic Surgery $72.18